tricentis tx3 life sciences [shutterstock: 750726223, Peshkova]
[shutterstock: 750726223, Peshkova]
Management Press Release

Tricentis Acquires Tx3

Tricentis has acquired Tx3 to help customers adapt best practices for ensuring compliance to the accelerated pace of today’s digital environment.

The life sciences industry is undergoing major change, driven by increasing competitive pressures, digital transformation initiatives, and the need for more streamlined, cost-efficient processes. While life sciences companies seek to reduce the time it takes to bring new products to market, the FDA and other regulatory agencies across the globe help to ensure that the new products are rigorously tested for safety and efficacy.

A comprehensive validation program is a necessity in the life sciences industry to ensure regulatory compliance, and to help companies maintain consistent quality across the software development lifecycle. Now, the complexity of this task is greatly increased as more life science companies adopt agile and DevOps methodologies.

By adding Tx3’s Vera solution for digital validation to the Tricentis portfolio, customers now have access to a computer systems validation approach that is resilient and convenient enough to be practical in the context of constant change. Together, Tricentis and Tx3 will provide a comprehensive solution that improves the validation process so customers can both meet stringent regulatory requirements and achieve their digital transformation goals.

Sign up for e3zine´s biweekly newsbites

Please do not use administrative mail adresses like "noreply@..", "admin@.." or similar as these may get blocked for security reasons.

We use rapidmail for dispatching our newsletter. By signing up, you agree that the data you have entered will be transmitted to rapidmail. Please take note of their terms and conditions and privacy policy.termsandconditions.

Our Authors